Results 11 to 20 of about 4,731 (194)

The structure of the NPC1L1 N-terminal domain in a closed conformation. [PDF]

open access: yesPLoS ONE, 2011
NPC1L1 is the molecular target of the cholesterol lowering drug Ezetimibe and mediates the intestinal absorption of cholesterol. Inhibition or deletion of NPC1L1 reduces intestinal cholesterol absorption, resulting in reduction of plasma cholesterol ...
Hyock Joo Kwon   +2 more
doaj   +4 more sources

NPC1L1 and cholesterol transport [PDF]

open access: yesFEBS Letters, 2010
The polytopic transmembrane protein, Niemann–Pick C1‐Like 1 (NPC1L1), is enriched in the apical membrane of small intestine absorptive enterocytes where it mediates extracellular sterol transport across the brush border membrane. It is essential for intestinal sterol absorption and is the molecular target of ezetimibe, a potent cholesterol absorption ...
Betters, Jenna L., Yu, Liqing
openaire   +3 more sources

Ezetimibe Blocks Internalization of the NPC1L1/Cholesterol Complex [PDF]

open access: yesCell Metabolism, 2008
Niemann-Pick C1-like 1 (NPC1L1) is a target for ezetimibe, a drug that blocks intestinal cholesterol absorption. A new study by Ge et al. (2008) in this issue of Cell Metabolism shows that non-lipoprotein-bound cholesterol induces endocytosis of NPC1L1 and that ezetimibe blocks the internalization of the NPC1L1/cholesterol complex.
Chang, Ta-Yuan, Chang, Catherine
openaire   +3 more sources

Kinetic imaging of NPC1L1 and sterol trafficking between plasma membrane and recycling endosomes in hepatoma cellss⃞

open access: yesJournal of Lipid Research, 2008
Niemann-Pick C1-like 1 (NPC1L1) is a recently identified protein that mediates intestinal cholesterol absorption and regulates biliary cholesterol excretion. The itineraries and kinetics of NPC1L1 trafficking remain uncertain.
Nicole Hartwig Petersen   +3 more
doaj   +2 more sources

Fomiroid A, a novel compound from the mushroom Fomitopsis nigra, inhibits NPC1L1-mediated cholesterol uptake via a mode of action distinct from that of ezetimibe. [PDF]

open access: yesPLoS ONE, 2014
Hypercholesterolemia is one of the key risk factors for coronary heart disease, a major cause of death in developed countries. Suppression of NPC1L1-mediated dietary and biliary cholesterol absorption is predicted to be one of the most effective ways to ...
Tomohiro Chiba   +8 more
doaj   +2 more sources

SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin [PDF]

open access: yesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
Curcumin, the major phenolic compound in the spice turmeric, exhibits numerous biological effects, including lowering plasma cholesterol and preventing diet-induced hypercholesterolemia. The mechanisms underlying the hypocholesterolemic effect of curcumin are not fully understood.
Pradeep, Kumar   +8 more
openaire   +3 more sources

The NPC1L1 Polymorphism 1679C>G Is Associated with Gallstone Disease in Chinese Patients. [PDF]

open access: yesPLoS ONE, 2016
Niemann Pick Type C1 Like 1 (NPC1L1) protein plays a key role in intestinal and hepatic cholesterol metabolism in humans. Genetic variation in NPC1L1 has been widely studied in recent years.
Jian Wu   +7 more
doaj   +2 more sources

Localization and role of NPC1L1 in cholesterol absorption in human intestine [PDF]

open access: yesJournal of Lipid Research, 2006
Recent studies have documented the presence of Niemann-Pick C1-Like 1 (NPC1L1) in the small intestine and its capacity to transport cholesterol in mice and rats.
Alain Théophile Sané   +7 more
doaj   +3 more sources

NPC1L1 knockout protects against colitis-associated tumorigenesis in mice [PDF]

open access: yesBMC Cancer, 2015
Colorectal cancer is strongly associated with lipid metabolism. NPC1L1, a sterol transporter, plays a key role in modulating lipid homeostasis in vivo. Its inhibitor, ezetimibe, began to be used clinically to lower cholesterol and this caused the great debate on its role in causing carcinogenesis.
He, Jianming   +5 more
openaire   +6 more sources

Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression [PDF]

open access: yesLipids in Health and Disease, 2010
Background Curcumin is a polyphenol and the one of the principle curcuminoids of the spice turmeric. Its antioxidant, anti-cancer and anti-inflammatory effects have been intensively studied. Previous in vivo studies showed that administration of curcumin
Duan Rui-Dong, Ohlsson Lena, Feng Dan
doaj   +3 more sources

Home - About - Disclaimer - Privacy